← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Southern Illinois University School Of Medicine
Springfield, IL
$10,334,898
Total funding
23
Grants
Funding over time
peak $2.1M · FY2010–22$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
DOD$9,712,329 · 19
NSF$622,569 · 4
By mechanism
—$10,334,898 · 23
Investigators at Southern Illinois University School Of Medicine
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
NICOTINIC RECEPTOR PATHOLOGY IN TINNITUS: AUDITORY CORTEX AND SELECTIVE DESENSITIZING NICOTINIC AGENTS$1,759,041
· FY2019 · Defense Health Agency
INVESTIGATION OF NOTCH SIGNALING DURING SPONTANEOUS REGENERATION OF COCHLEAR HAIR CELLS$1,496,416
· FY2015 · Department of the Army
DEVELOPMENT OF NEW THERAPIES THAT STIMULATE HAIR CELL REGENERATION$1,475,000
· FY2022 · Defense Health Agency
RESEARCH IN PERVENTION AND TREATMENT OF NOISE-INDUCED HEARING LOSS (NHL)$1,206,946
· FY2012 · Department of Defense
A NOVEL GABAA RECEPTOR SUBTYPE IN AUDITORY THALAMUS: A POTENTIAL NEW TARGET FOR TINNITUS TREATMENT$942,493
· FY2012 · Department of Defense
TARGETING ATTENTIONAL MECHANISMS IN TINNITUS: CONTRIBUTION OF THE THALAMIC CHOLINERGIC SYSTEM$661,326
· FY2016 · Department of the Navy
TARGETING TUMOR OCT4 TO DEPLETE PROSTATE TUMOR- AND METASTASIS-INITIATING CELLS$545,445
· FY2013 · Department of Defense
Toward a Descriptive Science of Learning Practices$490,778
· FY2002 · EDU
CELL SOURCE AND MECHANISM OF HAIR CELL REGENERATION IN THE NEONATAL MOUSE COCHLEA$398,500
· FY2014 · Department of Defense
CONFOCAL MICROSCOPE FOR THE INVESTIGATION OF HEARING LOSS, OTOPROTECTION, AND TINNITUS$270,433
· FY2015 · Department of the Navy
TARGETING QUIESCENT CANCER CELLS TO ELIMINATE TUMOR RECURRENCE AFTER THERAPY$147,500
· FY2014 · Department of Defense
A NOVEL THERAPY FOR METASTATIC MELANOMA$109,125
· FY2010 · Department of the Army
IDENTIFICATION AND RECONSTRUCTION OF PROSTATE TUMOR-SUPPRESSING EXOSOMES FOR THERAPEUTIC APPLICATIONS$109,125
· FY2014 · Department of Defense
THE ROLE OF MICRORNA EDITING IN BREAST CANCER$109,125
· FY2010 · Department of the Army
A NOVEL BIOTHERAPEUTIC FOR TRIPLE-NEGATIVE BREAST CANCER$109,125
· FY2010 · Department of the Army
ADENOSINE A3 RECEPTOR SUPPRESSES PROSTATE CANCER METASTASIS BY INHIBITING$109,125
· FY2011 · Department of the Army
PROSPECTING THE VENOM OF A TROPICAL PREDATORY ANT FOR ANTICANCER DRUG$109,125
· FY2010 · Department of the Army
THE ROLE OF TUMOR-ASSOCIATED MACROPHAGE IN RECURRENT GROWTH OF TUMOR STEM CELL$103,960
· FY2010 · Department of Defense
NANOG, CANCER STEM CELLS, AND RESISTANCE TO CHEMOTHERAPY$75,911
· FY2010 · Department of Defense
Coupling Theories of Learning and Research on Practice$67,487
· FY2003 · EDU